EverHint – Dip & Bounce Mean Reversion for Mar 17, 2026 – 18 Signals – Healthcare Leads (4)
10 signals (from 18 total). Healthcare leads (4). 5 with insider selling. price range $8-$1078. RSI 52-75. sectors: Healthcare (4), Industrials (2), Energy (2). 1 report earnings within 7 days. full analyst coverage, 33.3% have news.
EverHint Lens - Ondas Holdings Inc. (ONDS) - Yahoo Finance Most Active (50M+ volume) Stock Analysis - March 17, 2026
Ondas Holdings Inc. (ONDS): Technology company. trading at $10.66, up 1.3%.
EverHint Lens - Lemonade, Inc. (LMND) - Yahoo Finance Top Gainer (+16.7%) Stock Analysis - March 17, 2026
Lemonade, Inc. (LMND): Financial Services company. trading at $67.39, up 16.7%.
EverHint - Stock Market News — March 17, 2026 — Morning Update (last 12 hours, PT)
Wall Street pares gains as Trump slams NATO over Iran. Mastercard buys BVNK for $1.8B. Qualcomm $20B buyback. Warner CEO gets $887M Paramount payday. OpenAI-AWS government deal. Software debt selloff intensifies. Nvidia GTC: $1T demand "floor not ceiling." CTAs dump 75% equities. Fed decision Wed.
EverHint Lens - Telesat Corporation (TSAT) - Yahoo Finance Top Gainer (+16.20%) Stock Analysis - March 17, 2026
Telesat Corporation (TSAT): Technology company. trading at $41.25, up 16.2%.
EverHint – SMA20 × SMA50 Crossover – Top 7 Buy and Top 10 Sell Signals for Mar 16, 2026
17 signals (from 52 total). Industrials leads (15). 8 with insider selling. 1 with congressional selling. price range $8-$545. RSI 7-65. sectors: Industrials (15), Financial Services (11), Consumer Cyclical (9). 3 report earnings within 7 days. full analyst coverage, 46.2% have news.
EverHint – Volatility Squeeze Breakout – Top 2 Buy Signals for Mar 16, 2026
2 signals. Technology leads (1). price range $12-$59. RSI 68-70. sectors: Technology (1), Utilities (1). full analyst coverage, earnings data.
EverHint – Dip & Bounce Mean Reversion for Mar 16, 2026 – 9 Signals – Healthcare Leads (3)
9 signals. Healthcare leads (3). 5 with insider selling. price range $7-$289. RSI 52-71. sectors: Healthcare (3), Basic Materials (2), Utilities (1). 1 report earnings within 7 days. full analyst coverage, earnings data, 66.7% have news.
EverHint Lens - CytomX Therapeutics, Inc. (CTMX) - Top Gainer (+71%) Stock Analysis - March 16, 2026
CytomX Therapeutics, Inc. (CTMX): Healthcare company. trading at $8.01, up 71.2% (on Colorectal Cancer Data).
